Profile
| Role | Insider |
|---|---|
| Notability | 20/100 |
Board memberships
- Supernus Pharmaceuticals, Inc.
- KalVista Pharmaceuticals, Inc.
Updated Jul 16, 2026
Sensenig Bethany has filed 2 SEC Form 4 filings across 2 companies in the last 90 days — selling. Lifetime open-market sales: $455K.
| Role | Insider |
|---|---|
| Notability | 20/100 |
| Date | Ticker | Company | Code | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2026-04-17 | ACOG | Alpha Cognition Inc. | A — Grant or award | 5.5K | $0.00 | |
| 2026-02-23 | SUPN | SUPERNUS PHARMACEUTICALS, INC. | S — Open-market sale [10b5-1] | 3.3K | $51.27 | $167K |
| 2026-02-23 | SUPN | SUPERNUS PHARMACEUTICALS, INC. | S — Open-market sale [10b5-1] | 1.2K | $50.31 | $61K |
| 2026-02-23 | SUPN | SUPERNUS PHARMACEUTICALS, INC. | M — Option exercise [10b5-1] | 4.5K | $0.00 | |
| 2025-08-14 | SUPN | SUPERNUS PHARMACEUTICALS, INC. | S — Open-market sale | 5.4K | $42.25 | $227K |
Sensenig Bethany is a corporate insider — currently tracked as Insider of KalVista Pharmaceuticals, Inc. (KALV). InsiderAlpha tracks every SEC Form 4 filing in real time.
2 primary Form 4 filings in the last 90 days, covering 2 companies.
Recorded transactions: 0 open-market purchases () and 3 open-market sales ($455K) across all tracked filings.
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Open the live Sensenig Bethany profile on InsiderAlpha for real-time alerts, AI-scored trade ideas, and full transaction history.